Y-mAbs nets $135mm through public stock sale

19:40 EDT 31 Oct 2019 | Elsevier Business Intelligence

Y-mAbs Therapeutics Inc. netted $135mm through a public offering of 5.1mm common shares (including the overallotment) at $28....

Original Article: Y-mAbs nets $135mm through public stock sale


More From BioPortfolio on "Y-mAbs nets $135mm through public stock sale"

Quick Search

Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...